Patient-Friendly Explanation
Empagliflozin is a diabetes medicine that also helps some people lose weight by causing extra sugar to leave the body in the urine. It is prescribed mainly for type 2 diabetes and certain heart or kidney conditions, with weight loss as an added benefit.
Clinical Definition
Empagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor that reduces renal glucose reabsorption, promoting glycosuria and a modest calorie loss that results in weight loss of about two to three kilograms. It also improves cardiovascular and renal outcomes and lowers blood pressure.
Why It Matters
For patients with type 2 diabetes, heart failure, or kidney disease, empagliflozin offers weight loss alongside cardiorenal protection. NuLifeCare Singapore considers medications like empagliflozin within a comprehensive, doctor-supervised weight management plan.